Colonai

Curated by Signal

AI-based disease diagnosis tool for gastroenterologists

Overview

AI-based disease diagnosis tool for gastroenterologists. The company has developed software that assists with the analysis and detection of diseases. It has features for screening, detection, and tumor treatment.

Key facts

Founded: 2020
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Duke Heart On The Go
Online e-learning training program for healthcare professionals
Health TechnologyDurham, United States
HealthChain
Provider of blockchain-based inventory management solution
Health TechnologyNew York City, United States
A1wisdom
Provider of an online psychological testing application
Health TechnologySalt Lake City, United States

About Colonai

What does Colonai do?

AI-based disease diagnosis tool for gastroenterologists.

Where is Colonai headquartered?

Colonai is headquartered in New York City, United States.

When was Colonai founded?

Colonai was founded in 2020.

Which sector is Colonai in?

Colonai operates in Health Technology.

Who are Colonai's competitors?

Companies similar to Colonai include Duke Heart On The Go, HealthChain, and A1wisdom.